Lotus Pharmaceuticals, Inc. (LTUS)
OTCMKTS · Delayed Price · Currency is USD
0.0048
+0.0010 (26.32%)
At close: Feb 11, 2026
Lotus Pharmaceuticals Market Cap
Lotus Pharmaceuticals has a market cap or net worth of $12.69 million as of February 13, 2026. Its market cap has decreased by -56.89% in one year.
Market Cap
12.69M
Enterprise Value
n/a
Revenue
71.39M
Ranking
n/a
PE Ratio
0.08
Stock Price
$0.00
Market Cap Chart
Since October 4, 2006, Lotus Pharmaceuticals's market cap has decreased from 165.12M to 12.69M, a decrease of -92.31%. That is a compound annual growth rate of -12.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 12.69M | 60.00% |
| Dec 31, 2025 | 7.93M | -50.00% |
| Dec 31, 2024 | 15.87M | 26.79% |
| Dec 29, 2023 | 12.51M | -57.50% |
| Dec 30, 2022 | 29.45M | -41.00% |
| Dec 31, 2021 | 49.91M | 54.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Borealis Exploration | 10.88M |
| Atlantis Glory | 10.27M |
| SIPP International Industries | 9.91M |
| Maquia Capital Acquisition | 9.75M |
| Molecular Pharmacology (USA) | 9.70M |
| Elah Holdings | 8.87M |
| Black Box Entertainment | 8.64M |
| Unified Global | 8.40M |